ReportWire

Tag: Health Care

  • ‘A whole new world’: Georgia debuts all-terrain wheelchairs at its state parks | CNN

    ‘A whole new world’: Georgia debuts all-terrain wheelchairs at its state parks | CNN

    [ad_1]



    CNN
     — 

    Wheelchair users will now be able to explore Georgia’s state parks with free all-terrain wheelchairs.

    The new fleet of wheelchairs are part of a collaboration between the Georgia Department of Natural Resources and the Aimee Copeland Foundation, launched by Aimee Copeland, a social worker who in 2012 lost her both of her hands, one foot and most of one leg due to a rare bacterial, flesh-eating infection. The organization works to improve accessibility for disabled people, particularly through outdoor recreation.

    “All Terrain Georgia is the pride and joy of Aimee Copeland Foundation,” said Copeland in a news release from the Georgia Department of Natural Resources. “It’s been a long time coming and we’re honored to offer this life-changing program to the community.”

    The all-terrain wheelchairs allow wheelchair users to navigate more difficult terrain than they might be able to in an everyday wheelchair, according to the release. The chairs will be free with reservation at 11 state parks and historic sites in Georgia.

    The new wheelchairs were unveiled at Panola Mountain State Park, southeast of Atlanta, on November 4. Users will need to reserve the wheelchairs in advance and also have a designated “buddy” with them at all times.

    Georgia State Parks and Historic Sites Director Jeff Cown emphasized the importance of providing access to the outdoors for everyone in Georgia.

    “Our mission is to provide outdoor opportunities for every Georgia citizen and visitor,” said Cown in the release. “I am proud to partner with the Aimee Copeland Foundation to offer access to visitors with mobility or physical disabilities.”

    Georgia follows in the footsteps of Minnesota and Michigan, which have also introduced free all-terrain, electric-powered wheelchairs at their state parks.

    Cory Lee, the writer of a blog focused on traveling as a wheelchair user, told CNN that he’s excited to explore Georgia’s state parks using the new chairs.

    “It’ll open up a whole new world for me and for other wheelchair users,” he said.

    He added that many of the Georgia state parks he has visited are “lacking in accessibility.”

    “Some of them only have one accessible trail,” he said. “Now, there will be so many other trails that I’m able to do. I’m really looking forward to getting out on those trails soon.”

    Lee added that state parks should still focus on adding more wheelchair-accessible routes if possible. Getting out of his everyday wheelchair and into the all-terrain wheelchair can be challenging.

    Still, the all-terrain wheelchairs “are really a phenomenal resource,” he said.

    [ad_2]

    Source link

  • China eases some travel requirements in move welcomed by markets, even as it counts 10,000 new COVID cases in a day

    China eases some travel requirements in move welcomed by markets, even as it counts 10,000 new COVID cases in a day

    [ad_1]

    China counted more than 10,000 fresh COVID cases on Friday sparking further restrictions on movement, but also eased some travel requirements in a move welcomed by financial markets.

    Beijing closed city parks and imposed other restrictions, even as millions of people remained under lockdown Friday in the West and south of China, the Associated Press reported. 

    The country reported 10,729 new cases on Friday, almost all of them testing positive while showing no symptoms. More than five million people were under lockdown Friday in the southern manufacturing hub Guangzhou and the western megacity Chongqing.

    The government said Friday it was reducing the amount of time incoming passengers would be required to undergo quarantine. The U.S. Embassy this week renewed its advisement for citizens to avoid travel to and within China unless absolutely necessary.

    Incoming passengers will only be quarantined for five days, rather than the previous seven, at a designated location, followed by three days of isolation at their place of residence, according to a notice from the State Council, China’s cabinet.

    It wasn’t immediately clear when and where the rules would take effect and whether they would apply to foreigners and Chinese citizens alike.

    Relaxed standards would also be applied to foreign businesspeople and athletes, in what appeared to be a gradual move toward normalization. The news will be welcomed by Chinese citizens frustrated by the government’s zero COVID policy that has kept many in their homes sometimes for months at a time, and forced them to take regular tests.

    In the U.S., known cases of COVID are climbing again for the first time in a few months. The daily average for new cases stood at 40,835 on Thursday, according to a New York Times tracker, up 9% versus two weeks ago.

    As always, case numbers vary from state to state and some are seeing sharp spikes, led by Nevada, where cases have soared 176% from two weeks ago, the tracker shows. That’s followed by Utah, where they are up 77%, New Mexico at 62% and Oklahoma at 54%.

    Cases are rising in 32 states, as well as Washington, D.C., Guam, the U.S. Virgin Islands and Puerto Rico. They are up by double digits in 27 of those states.

    The daily average for hospitalizations was up 3% at 27,989, while the daily average for deaths is down 9% to 326. 

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Four German regions — Baden-Wuerttemberg, Bavaria, Hesse and Schleswig-Holstein — plan to scrap rules requiring people infected with the coronavirus to isolate at home, arguing that the pandemic has evolved and it’s time for a different approach, the AP reported. The health ministry pointed to declining infections, effective vaccinations, a high degree of population immunity, milder illnesses and the example of countries such as Austria that have loosened rules. “The decision doesn’t mean that we will give free rein to infections,” said Bavarian state health minister Klaus Holetschek. “People who test positive will in the future have to put on a mask outside their own apartment. And of course, the principle still goes that people who are sick stay at home.”

    • Sanofi
    SAN,
    -5.22%

    won European Union approval for its COVID vaccine booster, jointly made with British partner GSK
    GSK,
    -5.65%

    GSK,
    -6.01%
    ,
    after a drawn-out development effort that saw the pair fall behind now-dominant vaccine suppliers, Reuters reported. The shot with the brand name VidPrevtyn Beta can be given to people who have already had a primary course of vaccination from other approved shots, the French drugmaker and the European Medicines Agency said in separate statements. Shipments are ready to be distributed to European countries under advance purchase agreements, Sanofi said. The company said last year that the European Union and Britain had ordered a combined 75 million doses of the shot, contingent on approval.

    • U.S. Supreme Court Justice Sonia Sotomayor rejected a bid to prevent New York City from enforcing its COVID-19 vaccine mandate for municipal workers against a group of teachers, firefighters and others who challenged the policy, Reuters reported separately. The justice denied an emergency request, received by the court on Nov. 4, to block the policy by individual municipal workers, as well as a group called New Yorkers For Religious Liberty, while their appeal of lower court decisions siding with the city proceeds.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 634.3 million on Friday, while the death toll rose above 6.60 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 97.9 million cases and 1,074,485 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 227.8 million people living in the U.S., equal to 68.6% of the total population, are fully vaccinated, meaning they have had their primary shots.

    So far, just 31.4 million Americans have had the updated COVID booster that targets the original virus and the omicron variants, equal to 10.1% of the overall population.

    [ad_2]

    Source link

  • 10,000 brains in a basement: The dark and mysterious origins of Denmark’s psychiatric brain collection | CNN

    10,000 brains in a basement: The dark and mysterious origins of Denmark’s psychiatric brain collection | CNN

    [ad_1]

    Editor’s Note: Watch the special documentary, “World’s Untold Stories: The Brain Collectors,” November 12-13 on CNN International.



    CNN
     — 

    For years, there had been whispers. Rumors swirled; stories exchanged. It wasn’t a secret, but it also wasn’t openly discussed, adding to a legend almost too incredible to believe.

    Yet those who knew the truth wanted it out.

    Tell everyone our story, they said, about the brains in the basement.

    As a child, Lise Søgaard remembers whispers, too, though these were different – the family secret kind, hushed because it was too painful to speak it out loud.

    Søgaard knew little about it, except that these whispers centered on a family member who seemed to exist solely in one photograph on the wall of her grandparent’s house in Denmark.

    The little girl in the picture was named Kirsten. She was the younger sister of Søgaard’s grandmother, Inger – that much she knew.

    “I remember looking at this girl and thinking, ‘Who is she?’ ‘What happened?’” Søgaard said. “But also this feeling of a little bit of a horror story there.”

    As she grew into adulthood, Søgaard continued to wonder. One day in 2020, she went to visit her grandmother, now in her mid-90s and living at a care home in Haderslev, Denmark. After all that time, she finally asked about Kirsten. Almost as if Inger had been waiting for that very question, the floodgates opened, and out poured a story Søgaard never expected.

    Kirsten Abildtrup was born on May 24, 1927, the youngest of five brothers and her sister, Inger. As a child, Inger remembers Kirsten as quiet and smart, the two sisters sharing a close bond. Then, when Kirsten was around 14 years old, something began to change.

    Kirsten experienced outbursts and prolonged bouts of crying. Inger asked her mother if it was her fault, often feeling that way because the two girls were so close.

    “At Christmas, they were supposed to go on a visit to some family members,” Søgaard said, “but my great-grandmother and father, they stayed home and sent all of their children away except for Kirsten.”

    When they got back from that family visit, Søgaard said, Kirsten was gone.

    It was the first of many hospitalizations, and the start of a long and painful journey that would ultimately end in Kirsten’s death.

    The diagnosis: schizophrenia.

    Kirsten was first hospitalized towards the end of World War II, when Denmark and the rest of Europe were at last on the verge of peace.

    Like so many places, Denmark was also grappling with mental illness. Psychiatric institutions had been built across the country to provide care for patients.

    Doctors prepare a patient for electroshock therapy at Augustenborg Psychiatric Hospital in Denmark, 1943.

    But there was limited understanding of what was happening in the brain. The same year peace came to Denmark’s doorstep, two doctors working in the country had an idea.

    When these patients died in psychiatric hospitals, autopsies were routinely performed. What if, these doctors thought, the brains were removed – and kept?

    Thomas Erslev, historian of medical science and research consultant at Aarhus University, estimates that half of all psychiatric patients in Denmark who died between 1945 and 1982 contributed – unknowingly and without consent – their brains. They went to what became known as the Institute of Brain Pathology, connected to the Risskov Psychiatric Hospital in Aarhus, Denmark.

    Doctors Erik Stromgren and Larus Einarson were the architects. After roughly five years, said Erslev, pathologist Knud Aage Lorentzen took over the institute, and spent the next three decades building the collection.

    Dr. Larus Einarson, shown here teaching a class, was one of the co-founders of the brain collection at the Institute of Brain Pathology.

    The final tally would amount to 9,479 human brains – believed to be the largest collection of its kind anywhere in the world.

    In 2018, pathologist Dr. Martin Wirenfeldt Nielsen got a call. The brain collection, as it would come to be known, was on the move.

    A lack of funding meant it could no longer stay in Aarhus, but the University of Southern Denmark in the city of Odense had offered to pick up the mantle. Would Wirenfeldt Nielsen be interested in overseeing it?

    Pathologist Dr. Martin Wirenfeldt Nielsen now oversees the brain collection, housed in Odense, Denmark.

    “I’d sort of heard of it in the periphery,” Wirenfeldt Nielsen recalled. “But my first real knowledge about the vast extent of it was when they decided to move it down here … (because) how do you actually move almost 10,000 brains?”

    The yellowish-green plastic buckets housing each brain, preserved in formaldehyde, were placed into new white buckets that were sturdier for the transport, and hand-labeled in black marker with a number. And then the brains, give or take a few (no one knows where bucket #1 is, for example) made their way to their new home in a large basement room on the university’s campus.

    “The room wasn’t actually ready when they moved it down here,” Wirenfeldt Nielsen said. “The whole collection was just standing there, buckets on top of each other, in the middle of the floor. And that’s when I saw it for the first time … That was like, okay, this is something I’ve never seen before.”

    Eventually, the nearly 10,000 buckets were placed on rolling shelves, where they remain today – waiting – representing lives, and a range of psychiatric disorders.

    There are roughly 5,500 brains with dementia; 1,400 with schizophrenia; 400 with bi-polar disorder; 300 with depression, and more.

    What separates this collection from any other in the world is that the brains collected during the first decade are untouched by modern medicines – a time capsule of sorts, for mental illness in the brain.

    “Whereas other brain collections … (are) maybe specified for neurodegenerative diseases, dementia, tumors, or other things like that – we really have the whole thing here,” Wirenfeldt Nielsen said.

    But it has not been without controversy. In the 1990s, the Danish public got wind of the collection, which had been sitting idle since former director Lorentzen’s retirement in 1982.

    It would kick off one of the first major ethical science debates in Denmark.

    A history of The Brain Collection

    1945

    The Institute of Brain Pathology is founded, connected to the Risskov Psychiatric Hospital in Aarhus, Denmark

    Risskov, pictured here in the early 1900s.

    Credit: Museum Ovartaci

    1945-1982

    Nearly 9,500 brains are collected without permission from deceased psychiatric patients across the country

    Brains were collected and sent from Danish hospitals, including Rigshospitalet (pictured) in Copenhagen.

    Credit: Jesper Vaczy/Medical Museum

    1982

    The head of the brain collection, Knud Aage Lorentzen, retires. Nobody takes his place, and the collection sits untouched in a basement

    The brains, shown here in their original yellow buckets, would remain largely untouched for more than 20 years.

    Credit: Hanne Engelstoft

    1987

    The Danish Council of Ethics is established

    The Council of Ethics is an independent group formed to advise the Danish parliament (pictured here in 2016) on ethical matters.

    Credit: olli0815/iStock/Getty Images

    1991

    After the Council of Ethics says the brains can be used with certain restrictions in place, SIND (Denmark’s national association for psychiatric health) demands the brains be buried – sparking one of the first major ethical science debates in Denmark

    Some pieces of brain material are preserved in paraffin wax.

    Credit: Hanne Engelstoft

    2005

    Danish scientist Karl-Anton Dorph-Petersen takes over the collection’s daily maintenance at Aarhus

    Karl-Anton Dorph-Petersen helped revive and preserve the collection in the mid-2000s.

    Credit: Hanne Engelstoft

    2006

    The Council of Ethics goes against political and religious demands by ruling it is ethically sound to use deceased psychiatric patient brains for research without getting the consent of relatives. This time, SIND agrees

    The collection includes patient records and tissue preserved on slides, such as these.

    Credit: Hanne Engelstoft

    2017-2018

    A lack of funding threatens the brains, and the collection is saved by moving it to Odense, where Dr. Martin Wirenfeldt Nielsen takes over

    The brains were put into new white buckets to move to Odense, where they remain safely stored on rolling shelves.

    Credit: Samantha Bresnahan/CNN

    Source: Thomas Erslev, historian of medical science

    Graphic: Woojin Lee, CNN

    “There was a discussion back and forth, and one position was that we should destroy the collection – either bury the brains or get rid of them in any other ethical way,” said Knud Kristensen, the director of SIND, the Danish national association for mental health, from 2009 to 2021, and current member of Denmark’s Ethical Council. “The other position said, okay, we already did harm once. Then the least we can do to those patients and their relatives is to make sure that the brains are used in research.”

    After years of intense debate, SIND changed its position. “All of a sudden, they were very strong proponents for keeping the brains,” Erslev said, “actually saying this might be a very valuable resource, not only for the scientists, but for the sufferers of psychiatric illness because it might prove to benefit therapeutics down the line.”

    “For (SIND),” Kristensen said, “It was important where it was placed and to make sure that there would be some sort of control of the future use of the collection.”

    By the time it moved to Odense in 2018, the ethical debate was largely settled, and Wirenfeldt Nielsen became caretaker of the collection.

    A few years later, he would get a message from Søgaard. Was it possible, she asked, that he had a brain there belonging to a woman named Kirsten?

    In the search for what happened to her great aunt Kirsten, Søgaard realized there were clues all around her. But piecing together what exactly had happened to her grandmother’s sister was slow, filled with dead ends and false starts.

    Yet she was enthralled, and began officially reporting her journey for Kristeligt Dagblad, the Copenhagen-based newspaper where she worked – eventually bringing it to light in a series of articles.

    At one point, Søgaard decided to focus on a single word her grandmother had told her, the name of a psychiatric hospital: Oringe.

    “I opened my computer and I searched for ‘Oringe patient journals,’” she said. After putting in a request through the national archives, “I got an email that said, ‘Okay, we found something for you, come have a look if you want.’ … I felt this excitement … like, she’s out there.”

    Journalist Lise Søgaard made it her mission to find out what happened to her grandmother's little sister, Kirsten -- a journey that would take her places she never imagined. She shared that experience with CNN's Dr. Sanjay Gupta at her home outside Copenhagen in April 2022.

    That excitement was short-lived. At the national archives, they placed a mostly empty file in front of her. It wasn’t much to go on, but it confirmed Kirsten’s diagnosis of schizophrenia.

    Without another solid lead, Søgaard wondered where to go next. Then, almost in passing, as they looked through old family photos together, her mother said something that she’d never heard before.

    “She said, ‘You know, they might have kept her brain,’ and I said, ‘What?!’” Søgaard told CNN’s Dr. Sanjay Gupta at her house outside of Copenhagen. “And she told me what she knew about the brain collection.”

    At age 95, Søgaard’s grandmother, Inger, could still clearly picture visiting her little sister Kirsten in the hospital, after the symptoms she first started experiencing at age 14 continued to progress.

    Upon one visit, Inger remembered, “(Kirsten) was lying there, completely apathetic. She was not able to speak to us. … Another day we went to visit her, and she was gone from her room. They told us she had thrown a glass at a nurse, and they had sent her to the basement, to a room where they (restrained) her with belts. And we were not allowed to go in, but I saw her through a hole in the door; she was lying there, strapped up.”

    One floor of the Oringe psychiatric hospital is now a museum, which displays medical treatments and patient rooms such as this one.

    Inger felt confused and scared, she said, because it could have been anyone, including her, that might get “sick.”

    At Sankt Hans, one of the largest and oldest psychiatric hospitals in Denmark, Dr. Thomas Werge walks the same grounds he did as a child, when his own grandmother was hospitalized there. Now, he runs the Institute for Biological Psychiatry there, where he and his team study the biological causes that contribute to psychiatric disorders.

    A 2012 study found that roughly 40% of Danish women and 30% of Danish men had received treatment for a mental health disorder in their lifetimes – though Werge estimated that number would “almost certainly” be higher if the same study was done today. (By comparison, that same year, less than 15% of US adults received mental health services.) Among the other Nordic countries, including Sweden and Norway, Werge said the numbers would be comparable to Denmark’s, as there are “similar [universal] health care systems and standards for admission.”

    “Mental (health) disorders are all over,” he added. “We just do not recognize this when we walk around among people. Not everybody carries their pain on the outside.”

    For schizophrenia, there are no blood tests or biomarkers to signify its presence; instead, doctors must rely only on a clinical exam.

    Schizophrenia presents itself in what the World Health Organization (WHO) calls “significant impairments in the way reality is perceived,” causing psychosis that can include delusions, hallucinations, disorganized behavior or thoughts, and extreme agitation.

    Roughly one in 300 people are affected by schizophrenia worldwide, according to the WHO, but less than one-third of those will ever receive specialist mental health care.

    denmark cemetery of the brainless spc intl_00013202.png

    Visiting a ‘cemetery of the brainless’ in Denmark


    02:10

    – Source:
    CNN

    The standard treatment since the mid-1950s has been anti-psychotic drugs, which typically work by manipulating dopamine levels: the brain’s reward system. But, Werge said, it can come with a cost.

    “Schizophrenia and psychosis are linked to creativity,” he said. “So, when you try to inhibit the psychosis, you also inhibit the creativity. So, there’s a price for being medicated … Whatever causes all these problems for humans is also what makes us humans in the good sense.”

    Though there haven’t been many significant scientific breakthroughs regarding an understanding of the disease, researchers have confirmed that genetics and heritability play a significant role.

    According to Werge, the heritability estimate is as high as 80% – the same as height. “It’s not a surprise to people that if you have very tall parents … there’s a lot of genetics in that,” he said. “The genetic component is equally large in most of the mental disorders actually.”

    Those inherited genetic factors either come from the parents, he added, or can arise in a child even if the parents don’t carry the gene.

    Søgaard, who has two young children, said the genetic connection was not a driving motivator in her mission to find out what happened to Kirsten, but she has thought about what it means for herself and her family.

    When families reach out about possible relatives in the brain collection, “that’s an ethical dilemma that we need to take into consideration,” Wirenfeldt Nielsen said. In Søgaard’s case, she received approval for the Danish National Archives to check the set of black books that contain the names of every person whose brain is in the collection.

    There on the list was Kirsten’s name.

    “I got an email back [from the National Archives], and they scanned the page where Kirsten’s name was, and her birthday, and the day they received the brain. And in the column out to the left, there was a number,” Søgaard remembered. “Number 738.” She immediately wrote an email to Wirenfeldt Nielsen, asking if that number corresponded to the bucket with Kirsten’s brain.

    “I said, ‘Yes, that’s it,’” Wirenfeldt Nielsen recalled. But he also said he couldn’t be sure the bucket was there because a few are missing for unknown reasons. He ventured down to the basement storage room to verify it was there.

    On one of the rolling shelves sat bucket #738.

    Kirsten’s brain.

    Bucket #738 -- Kirsten's brain -- sits on a shelf among the rest of the brain collection in the basement at the University of Southern Denmark in Odense.

    When Søgaard first saw it, she felt compelled to hug the bucket.

    “I had learned a lot about Kirsten,” she said. “I feel some kind of connection … (and) I know the pain that she felt, and I know what she went through.”

    What Kirsten went through was another extraordinary beat in this incredible story, and the long history of psychiatric care in Denmark.

    As part of her treatment, Kirsten received what’s known commonly in Denmark as “the white cut.”

    In medical terms: a lobotomy.

    The procedure was an integral part of the country’s psychiatric history. During the time the brain collection was running from the 1940s until the early 1980s, Denmark reportedly did more lobotomies per capita than any other country in the world.

    01 denmark brain sanjay

    A look at the brain like you’ve never seen it before


    03:08

    – Source:
    CNN

    “It’s a very poor treatment, because you destroy a big part of the brain,” Wirenfeldt Nielsen said. “And it’s very risky, because you can kill the patient, basically – but they had nothing else to do.”

    Treatment options were limited, and in many ways extreme. Seizures were induced by placing electrodes on either side of the head; insulin shock therapy meant patients were administered large doses of insulin, reducing blood sugar and resulting in a comatose state; and the lobotomy, either transorbital – using a pick-like instrument inserted through the back of the eye to the front lobe – or prefrontal.

    The prefrontal lobotomy was pioneered by a Portuguese neurologist, Antonio Egas Moniz. Now considered barbaric, he actually won the Nobel Prize for the procedure in 1949.

    A tool is inserted into the frontal lobe, scraping away tracts of white matter – the reason behind the “white cut” moniker. “Emotional reactions … are located at least in part in the frontal lobe,” explained Wirenfeldt Nielsen, “so they thought that just by cutting (there), that could sort of calm the patient down.”

    Left: Portuguese neurologist Antonio Egas Moniz was awarded the Nobel Prize in 1949 for pioneering the prefrontal lobotomy.
Upper right: Lobotomies became a popular treatment option from the 1930s to the early 1950s. Here, a surgeon drills into a patient's skull at a hospital in England, 1946.
Lower right: By cutting tracts through brain matter in the frontal lobe, the belief was the lobotomy could treat symptoms of mental illness.

    In Kirsten’s case, Inger said there were glimpses of “the old Kirsten” before she got the white cut – but after that, she was gone. In 1951, the year after her lobotomy, Kirsten died.

    She was just 24 years old.

    On a metal table in a small, standalone building on the grounds of Oringe psychiatric hospital, Kirsten’s brain was removed, set into a small plastic bucket, placed in a wooden box, and shipped – by regular mail carrier – to the Institute of Brain Pathology at Risskov, to join the brain collection.

    Søgaard saw the metal table, where a white wooden block still sits on one end – where the heads were placed – and upon which small marks are still visible today. This is where the skulls were opened.

    The standalone building at Oringe (left) housing the autopsy room where Kirsten's brain was removed in 1951 still stands today, and includes the wooden boxes (right) that were once used to ship the brains to Risskov.

    Despite the graphic reminders, in reporting out this story both for herself, and for the newspaper, “it was important (for me) to not write a story that was a horror story,” she said, adding it was easy to look back and say, “How could you do that?”

    “I don’t think the doctors wanted to do bad. I think they actually wanted to do good. … I think the most ethical thing you can do is to make sure that you know exactly what you can do with these brains. And that’s what they’re doing now. They’re trying to find out, ‘How can they help us?’”

    There have been studies using the collection over the years, including a discovery in 1970 of what is now known as familial Danish dementia, and a new study is ongoing, focused on mRNA in the brains, by Danish researcher Betina Elfving.

    For the most part, the brains represent untapped, enormous potential. Yet the one in bucket #738 has already done something extraordinary, thanks in large part to Søgaard herself. She worked to break the cycle of stigma surrounding mental health disorders by sharing her most personal, intimate family details with the world.

    “(My grandmother) expressed gratitude,” Søgaard said. “She also said, ‘I feel like I’m moving closer to my sister now.’”

    [ad_2]

    Source link

  • Australia blames cyber criminals in Russia for Medibank data breach | CNN Business

    Australia blames cyber criminals in Russia for Medibank data breach | CNN Business

    [ad_1]


    Brisbane, Australia
    CNN
     — 

    Cyber criminals in Russia are behind a ransomware attack on one of Australia’s largest private health insurers that’s seen sensitive personal data published to the dark web, the Australian Federal Police (AFP) said Friday.

    In a short press conference, AFP Commissioner Reece Kershaw told reporters investigators know the identity of the individuals responsible for the attack on health insurer Medibank, but he declined to name them.

    “The AFP is undertaking covert measures and working around the clock with our domestic agencies and international networks including Interpol. This is important because we believe those responsible for the breach are in Russia,” he said.

    Medibank says the stolen data belongs to 9.7 million past and present customers, including 1.8 million international customers. The files include health claims data for almost half a million people, including 20,000 based overseas.

    This week, the group started releasing curated tranches of customer data onto the dark web, in files with titles including good-list, naughty-list, abortions and boozy, which included those who sought help for alcohol dependency.

    Kershaw said police intelligence points to a “group of loosely affiliated cyber criminals” who are likely responsible for previous significant data breaches around the world, without naming specific examples.

    “These cyber criminals are operating like a business with affiliates and associates who are supporting the business. We also believe some affiliates may be in other countries,” said Kershaw, who declined to take questions due to the sensitivity of the investigation.

    Cyber security experts have said the criminals are likely linked to REvil, a Russian ransomware gang notorious for large attacks on targets in the United States and elsewhere, including major international meat supplier JBS Foods last June.

    That breach shut down the company’s entire US beef processing operation and prompted the company to pay an $11 million ransom. Last November, the US State Department offered a $10 million reward for information leading to the identification or location of key leaders of REvil, also known as the Sodinokibi organized crime group.

    In mid-January, Russian state news agency TASS reported that at least eight REvil ransomware hackers had been detained by Russia’s Federal Security Service (FSB) at the request of the US.

    They were facing charges of committing “illegal circulation of payments,” a crime punishable by up to seven years in prison, TASS reported, citing Moscow’s Tverskoi Court.

    In March, Ukrainian national Yaroslav Vasinskyi, one of the chief suspects linked to an attack on US software vendor, Kaseya, was extradited from Poland to the US to face charges, according to a statement from the Justice Department.

    Jeffrey Foster, associate professor in cyber security studies at Macquarie University, said there’s one major link between the REvil network and the group suspected of hacking the Medibank network.

    “The biggest link is that the REvil dark web website now redirects to this website. So that’s the biggest link we have between them, and the only link we have between them,” said Foster, who is monitoring the blog where the group is posting their demands.

    “As Russia has stated that they’ve arrested and disbanded REvil, it seems likely this is a case of maybe a former REvil member, who had access to the dark web website to be able to do the redirect which requires access to the hardware,” he said. “Whether or not REvil has returned, we don’t know.”

    Medibank first detected unusual activity in its network almost a month ago. On October 20, the company issued a statement saying a “criminal” had stolen information from its ahm health insurance and international student systems, including names, addresses, phone numbers and some claims data for procedures and diagnoses.

    An initial ransom demand was made for $10 million (15 million Australian dollars), but the company said after extensive consultation with cybercrime experts it had decided not to pay. It was later lowered to $9.7 million – one for every customer affected, according to Foster.

    At the time, Medibank said there was only a “limited chance” that paying the ransom would stop the data being published or returned to the company.

    In his statement on Friday, Kershaw, the AFP Commissioner, said Australian government policy did not condone paying ransoms to cyber criminals.

    “Any ransom payment small or large fuels the cybercrime business model, putting other Australians at risk,” he said.

    Kershaw said investigators at the Australian Interpol National Central Bureau would be talking with their Russian counterparts about the individuals, who he addressed directly with a threat to see them charged in Australia.

    “To the criminals, we know who you are. And moreover, the AFP has some significant runs on the scoreboard when it comes to bringing overseas offenders back to Australia to face the justice system,” he said.

    Earlier Friday, Australian Prime Minister Anthony Albanese said he was “disgusted” by the attacks and, without naming Russia, said the government of the country they come from should be held accountable.

    “The nation where these attacks are coming from should also be held accountable for the disgusting attacks, and the release of information including very private and personal information,” Albanese said.

    In a statement Friday, Medibank CEO David Koczkar said it was clear the criminal gang behind the breach was “enjoying the notoriety,” and it was likely they would release more information each day.

    “The relentless nature of this tactic being used by the criminal is designed to cause distress and harm,” he said. “These are real people behind this data and the misuse of their data is deplorable and may discourage them from seeking medical care.”

    [ad_2]

    Source link

  • WHO says 90% decline in COVID deaths since Feb. is ’cause for optimism,’ while urging vigilance against new variants

    WHO says 90% decline in COVID deaths since Feb. is ’cause for optimism,’ while urging vigilance against new variants

    [ad_1]

    The head of the World Health Organization said a close to 90% decline in COVID deaths globally compared to nine months ago is “cause for optimism,” but urged leaders to remain vigilant as new variants continue to emerge.

    Tedros Adhanom Ghebreyesus told reporters on Wednesday that there were just 9,400 COVID deaths last week, compared with more than 75,000 in February, the Associated Press reported. 

    “Almost 10,000 deaths a week is 10,000 too many for a disease that can be prevented and treated,” he said.

    Testing and sequencing rates remain low globally, vaccination gaps between rich and poor countries are still wide, and new variants continue to proliferate.

    In its weekly epidemiological update, the agency said the global tally of cases fell 15% in the week through Nov. 6 from the previous week with over 2.1 million new cases counted.

    The highest number of new cases was reported from Japan, at 401,693, followed by Korea at 299,440 and the U.S. at 266,104. The agency again cautioned that the numbers may be undercounted, given the changes in testing strategies and overall surveillance in many countries, including the U.S.

    As for new variants, the update found BA.5, an omicron subvariant, remained dominant globally, accounting for 74.5% of sequences submitted to a central database. But newer ones, including BQ.1 and XBB, are on the rise.

    BQ.1 sequences rose to 13.4% of the total from 9.4% a week ago. XBB rose to 2.0% from 1.1%. The WHO is still closely monitoring newer sublineages but called on countries to also track them closely.

    In the U.S., known cases of COVID are climbing again for the first time in a few months. The daily average for new cases stood at 40,189 on Wednesday, according to a New York Times tracker, up 7% versus two weeks ago.

    Cases are rising extremely sharply in some states, led by Nevada, where they are up 96% from two weeks ago. New Mexico’s case tally has climbed 64% from two weeks ago and Utah is up 61%. Overall, cases are rising in 32 states and are flat in Delaware. They are also rising in Washington, D.C., Guam, Puerto Rico and the U.S. Virgin Islands.

    The daily average for hospitalizations was up 3% at 28,003, while the daily average for deaths is down 13% to 316.

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • China’s new top leadership body reaffirmed Beijing’s “dynamic-zero” COVID-19 policy on Thursday, as case numbers rose and authorities in the city of Guangzhou urged residents to work from home but stopped short of a citywide lockdown, Reuters reported. In its first meeting since being formed last month after the ruling Communist Party’s twice-a-decade congress, the Politburo Standing Committee said China’s epidemic prevention measures must not be relaxed, according to state media.

    • AstraZeneca PLC on Thursday lifted its guidance for the full year after reporting a swing to net profit and higher sales for the third quarter of the year, which both beat consensus expectations, Dow Jones Newswires reported. The Anglo-Swedish drug company dropped its submission for U.S. regulatory approval for its COVID vaccine, saying it has decided to focus instead on areas with greater unmet medical needs. The vaccine was initially approved in the U.K. and Europe about two years ago. CEO Pascal Soriot said the submission in the U.S. was becoming “very complicated and very large,” as it had to gather data from around the world.

    • Pfizer
    PFE,
    +1.41%

    and German partner BioNTech
    BNTX,
    -1.67%

    said Thursday that their booster dose of the omicron BA.4/BA.5-adapted bivalent COVID vaccine for 5-to-11 year olds was recommended for marketing authorization in the European Union. The EU will review the recommendation from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP), and is expected to make a decision “soon.” The companies’ bivalent booster is already authorized in the EU for people at least 12 years old.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 633.9 million on Monday, while the death toll rose above 6.60 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 97.9 million cases and 1,073,934 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 227.3 million people living in the U.S., equal to 68.5% of the total population, are fully vaccinated, meaning they have had their primary shots.

    So far, just 26.3 million Americans have had the updated COVID booster that targets the original virus and the omicron variants, equal to 8.4% of the overall population.

    [ad_2]

    Source link

  • Manufacturing hub Guangzhou is latest Chinese city to face lockdowns as COVID cases rise

    Manufacturing hub Guangzhou is latest Chinese city to face lockdowns as COVID cases rise

    [ad_1]

    The southern Chinese manufacturing hub of Guangzhou is the latest to see lockdowns amid a surge in COVID-19 cases, as the government presses ahead with the strict zero-COVID policy that has frustrated citizens.

    The latest lockdowns have further disrupted global supply chains and sharply slowed growth in the world’s second-largest economy, as the Associated Press reported.

    Residents in districts encompassing almost 5 million people have been ordered to stay home at least through Sunday, with one member of each family allowed out once a day to purchase necessities, local authorities said Wednesday.

    The order came after the densely populated city of 13 million reported more than 2,500 new cases over the previous 24 hours.

    China has retained its strict zero-COVID policy despite relatively low case numbers and no new deaths. The country’s borders remain largely closed, and internal travel and trade is complicated by ever-changing quarantine regulations.

    Apple
    AAPL,
    -3.32%

    and iPhone manufacturer Foxconn
    2317,
    -1.95%

    said over the weekend that restrictions are crimping production and will delay shipments of the high-end iPhone 14.

    For more, read: All eyes on China as Apple and Foxconn outline zero-COVID issues. Meanwhile, cases are rising again in the U.S.

    In the U.S., known cases of COVID are climbing again for the first time in a few months. The daily average for new cases stood at 39,578 on Tuesday, according to a New York Times tracker, up 5% versus two weeks ago.

    As always, the increase in cases is not uniform across the nation. Some states are seeing sharp spikes, led by Nevada, where cases are up 96% from two weeks ago. Tennessee is second with cases up 69%, followed by Louisiana with cases up 68%, New Mexico, where they are up 62%, and Utah, where they have climbed 61%.

    Cases are up by a double-digit percentage in 22 states.

    The daily average for hospitalizations was up 3% to 27,713, while the daily average for deaths was down 14% to 308.

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Novavax Inc.
    NVAX,
    -5.19%

    on Tuesday tweaked its full-year sales outlook to the low end of its expected range and reported a surprise quarterly loss, but sales for the COVID-19 vaccine maker were far better than expected. The company reported a net loss of $168.6 million, or $2.15 a share, compared with a loss of $322.4 million, or $4.31 a share, in the same quarter a year ago. Sales were $735 million, compared with $178.8 million in the prior-year quarter. Analysts polled by FactSet expected Novavax to earn $1.57 a share on revenue of $586 million.

    • A Food and Drug Administration advisory committee said this week that Veru Inc.’s
    VERU,
    +3.95%

    COVID treatment Sabizabulin demonstrated a clear clinical benefit with a favorable benefit-to-risk profile. Veru is seeking emergency-use authorization for treatment of hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome.

    • A Massachusetts man who admitted to lying on his application for federal coronavirus business stimulus funds and using some of the $400,000 he received to pay his mortgage has been sentenced to 15 months in prison, federal prosecutors said, as the AP reported. In addition to the time behind bars, Adley Bernadin, 44, of Stoughton, was sentenced last week to three years of supervised release and ordered to forfeit more than $280,000, according to a statement from the U.S. attorney’s office.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 633.5 million on Monday, while the death toll rose above 6.60 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 97.8 million cases and 1,072,943 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 227.3 million people living in the U.S., equal to 68.5% of the total population, are fully vaccinated, meaning they have had their primary shots.

    So far, just 26.3 million Americans have had the updated COVID booster that targets the original virus and the omicron variants, equal to 8.4% of the overall population.

    [ad_2]

    Source link

  • The IRS is making big changes to FSAs and HSAs. Here’s what to know.

    The IRS is making big changes to FSAs and HSAs. Here’s what to know.

    [ad_1]

    Employers typically offer a period of open enrollment in the fall, when their workers are allowed to pick new health plans, enroll in a Flexible Spending Account or make other changes to their benefits. This year, there are some changes ahead that could help  employees, while also potentially opening up some financial pitfalls. 

    Among the biggest changes for 2023 are with two tax-advantaged health savings accounts — Flexible Spending Accounts (FSA) and Health Savings Accounts (HSA). These accounts can save workers a nice chunk of change by allowing them to sock away pre-tax money to pay for medical expenses. Basically, you save what you would have paid in taxes on money you put in the accounts. 

    In 2023, employees can put away as much as $3,050 in an FSA, an increase of about 7% from the current tax year’s cap of $2,850. Meanwhile, single workers who want to fund an HSA can save up to $3,850 next year, a 5.5% increase from 2022, while families can save up to $7,750, up 6.2%.

    Those increases are helpful at a time when inflation is at it highest in four decades, with consumer prices having jumped more than 8% from a year ago. But there are several “gotchas” that workers need to be aware of, especially when it comes to Flexible Spending Accounts, with the foremost being that FSAs are “use-it-or-lose-it” programs. In other words, if you don’t use all the money you set aside, you’ll lose it — your employer keeps any unused funds.

    “Open enrollment typically opens in late October and early November,” said Lisa Myers, director of client services, benefits accounts, at Willis Towers Watson. “Planning carefully is important, and knowing the deadlines.”

    Indeed, U.S. workers end up forfeiting a total of about $3 billion a year in unused FSA funds, according to an analysis from Money. 

    Here’s what to consider during open enrollment. 

    What’s the difference between an FSA and HSA? 

    Both accounts are aimed at helping workers pay for medical expenses with pre-tax money. The biggest difference is that FSAs are controlled by your employer, while HSAs are owned by the individual. 

    That means that if you leave your job, your FSA won’t move with you. But once you open and fund an HSA, that account does stay with you, like your 401(k), which continues to be yours even after you leave a job and start at a new employer. 

    Another big difference: Health Savings Accounts are designed for people with high-deductible health care plans. This means that not every employee will have access to an HSA. 

    HSAs generally have more flexibility than FSAs. For instance, unused funds roll over each year, unlike with a FSA, where funds are forfeited if not used by your employer’s claim deadline. And you can change your contributions to your HSA at any time; with a FSA, contributions are set during open enrollment. 

    “Funds go into this account on a pre-tax basis, they can grow over time, including be invested, and as long as they’re eventually used on medical expenses is also tax free,” Stephen Durso, associate director of benefit accounts at Willis Towers Watson, told CBS News. 

    “So that kind of triple-tax savings benefit is really unmatched based on the available types of accounts. If you have an HSA available, it really is an attractive option for you,” he added.

    Can I enroll in both an FSA and HSA? 

    Generally, no, noted Myers of Willis Towers Watson. However, people with HSAs can opt for a slimmed-down version of a Flexible Spending Account, known as a “limited purpose FSA.” These accounts can only be used for vision and dental expenses, which shrinks their usefulness.

    That means employees who qualify for both programs will generally need to decide whether it makes more sense to fund either an FSA or an HSA for 2023.

    How much should I set aside for 2023?

    Some employers offer tools to help workers estimate their potential annual health costs, but you can also look at your out-of-pocket medical expenses for the past year to help gauge your likely expenditures for the upcoming year, Myers said.

    People with HSAs also may want to set aside the amount that they’ll pay due to their health plan deductible, since that’s out-of-pocket spending that they could get reimbursed through that tax-advantaged account. 

    There’s more at stake for people who are opting for FSAs, since overestimating your medical expenses could leave money sitting in your account that eventually returns to your employer. 

    What deadlines should I be aware of? 

    You’ll need to stay on top of the deadline for claiming your FSA funds. 

    Employers can give employees a grace period of up to two and a half months after the end of a calendar year to claim the money. But you’ll have to check if your company offers extra time and mark on your calendar when you’ll need to claim the money by.

    Some employees may be surprised by deadlines this year because a pandemic stimulus bill and the IRS relaxed the rules for claiming FSA funds, providing more time for people to file claims in 2020 and 2021. But those provisions have expired, which means people with FSAs in 2022 must claim their money by year-end or by an employer’s grace period in early 2023.

    “That was temporary relief due to the pandemic, so employees may have larger than usual balances in their health and dependent-care FSAs, and that they may forfeit going into 2023,” Myers said. “It’s important to check your balances, check the plan rules, so they can plan their spending for the remainder of 2022.”

    What can I spend my FSA money on?

    Employees are sometimes surprised at what their FSA plans will cover, including Band-Aids, reading glasses, first-aid kits and over-the-counter medicine, Myers said. 

    She recommends that people check the FSAStore.com, which carries all FSA-eligible items, especially if you are getting close to your deadline for claiming your funds and need to use the money. 

    Myers also advises that you check your 2022 FSA balance and claim deadlines now, rather than waiting until the end of the year. Generally, a health service or good must be purchased in 2022 to qualify for a 2022 FSA claim, so waiting until the last minute to try to spend the funds could increase your risk of running into a barrier — such as if your eye doctor is booked up, which could hinder renewing your prescription to get new glasses.

    [ad_2]

    Source link

  • All eyes on China as Apple and Foxconn outline zero-COVID issues. Meanwhile, cases are rising again in the U.S.

    All eyes on China as Apple and Foxconn outline zero-COVID issues. Meanwhile, cases are rising again in the U.S.

    [ad_1]

    China’s strict zero-COVID policy was making headlines Monday after Apple and iPhone manufacturer Foxconn said over the weekend that restrictions are crimping production and will delay shipments of the high-end iPhone 14.

    “We continue to see strong demand for iPhone 14 Pro and iPhone 14 Pro Max models,” Apple
    AAPL,
    -0.82%

    announced in a Sunday evening press release. “However, we now expect lower iPhone 14 Pro and iPhone 14 Pro Max shipments than we previously anticipated and customers will experience longer wait times to receive their new products.” 

    Also read: Will Apple’s latest production issues destroy demand?

    Foxconn, meanwhile, which trades as Hon Hai Precision Industry Co.
    2317,
    -0.50%
    ,
    lowered its fourth-quarter guidance and said anti-COVID measures were affecting some of its operations in Zhengzhou, China, as Dow Jones Newswires reported.

    Foxconn said that the Henan provincial government had made it clear that it would fully support the company. Foxconn’s most advanced iPhone plant, located in the provincial capital of Zhengzhou, has been battling a COVID outbreak.

    Foxconn said it is working with the government to halt the outbreak and resume production at full capacity as quickly as possible.

    Workers at the world’s biggest assembly site for Apple’s iPhones walked out last week as Foxconn struggled to contain a COVID-19 outbreak. The chaos highlighted the tension between Beijing’s rigid pandemic controls and the need to keep production on track. Photo: Hangpai Xinyang/Associated Press

    Investors have been closely watching China for signs that its government would start to lift the tough pandemic restrictions that have been in place for almost three years. The Wall Street Journal reported Monday that the country’s leaders are considering steps but have not yet set a timeline.

    Chinese  officials have become concerned about the costs of their zero-tolerance approach to COVID, which has resulted in lockdowns of cities and whole provinces, crushing business activity and confining hundreds of millions of people to their homes for weeks and sometimes months on end.

    But they are weighing those concerns against the potential costs of reopening on public health and on support for the Communist Party. On Saturday, officials from China’s National Health Commission again reaffirmed their commitment to a firm zero-COVID strategy, which they described as essential to “protect people’s lives.”

    Still, there are plans in Beijing to further cut the number of days incoming travelers must quarantine in hotels from 10 to seven, followed by three days of home monitoring, the paper reported, citing people involved in the discussions.

    And officials have told retail businesses that they intend to reduce the frequency of PCR testing as soon as this month, partly because of the cost.

    In the U.S., known cases of COVID and hospitalizations are climbing again for the first time in a few months.

    The daily average for new cases stood at 39,954 on Sunday, according to a New York Times tracker, up 6% compared with two weeks ago. But cases are sharply higher in several states, led by Nevada, where they are up 96% from two weeks ago, followed by Tennessee, where they are up 69%; Louisiana, where they are up 68%; Utah, where they have climbed 61%; and New Mexico, where they are up 56%.

    Cases are climbing in 30 states and in Washington, D.C.

    The daily average for hospitalizations was up 2% to 27,419, while the daily average for deaths was down 11% to 320.

    Physicians are reporting high numbers of respiratory illnesses like RSV and the flu earlier than the typical winter peak. WSJ’s Brianna Abbott explains what the early surge means for the winter months. Photo illustration: Kaitlyn Wang

    The Centers for Disease Control and Prevention said the BQ.1 and BQ.1.1 variants accounted for 35.3% of new cases in the week through Nov. 5, up from 27.1% a week ago.

    The two variants accounted for 52.3% of all cases in the New York region, which includes New Jersey, Puerto Rico and the Virgin Islands, up from 42.5% the previous week. That was more than the BA.5 omicron subvariant, which accounted for 24.9% of new cases in the New York area in the latest week.

    The BA.5 omicron subvariant accounted for 39.2% of all U.S. cases, the data show.

    BQ.1 and BQ.1.1 were still lumped in with BA.5 variant data as recently as three weeks ago, because at that time, their numbers were too small to break out. BQ.1 was first identified by researchers in early September and has been found in the U.K. and Germany, among other places. 

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • BioNTEch SE
    BNTX,
    +2.84%
    ,
    the German biotech that has partnered with Pfizer
    PFE,
    -0.53%

    on a COVID vaccine, posted earnings early Monday, showing a roughly 50% drop in profit that sent its stock lower, despite beating consensus estimates. The Mainz-based company said it had invoiced about 300 million doses of its bivalent vaccine, which targets the omicron variant as well as the original virus. The company chalked up €564.5 million ($563.9 million) in direct COVID vaccine sales in the quarter, down from €1.351 billion a year ago. BioNTech raised the lower end of its full-year COVID vaccine revenue range to €16 billion to €17 billion, from a previous €13 billion to €17 billion.

    • Thousands of runners took to the streets of the Chinese capital on Sunday for the return of Beijing’s annual marathon after a two-year hiatus, the Associated Press reported. However, the good news was offset by anger about another death related to COVID restrictions, this time of a 55-year-old woman in a sealed building. An investigation report released Sunday in Hohhot, the capital of China’s Inner Mongolia region, blamed property management and community staff for not acting quickly enough to prevent the death of the woman after being told she had suicidal tendencies.

    • The U.S. flu season is off to an unusually fast start, contributing to an autumn mix of viruses that have patients filling hospitals’ and physicians’ waiting rooms, the AP reported separately. Reports of flu are already high in 17 states, and the hospitalization rate hasn’t been this high this early since the 2009 swine flu pandemic, according to the Centers for Disease Control and Prevention. So far, there have been an estimated 730 flu deaths, including at least two children. The winter flu season usually ramps up in December or January.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 632.6 million on Monday, while the death toll rose above 6.60 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 97.7 million cases and 1,072,598 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 227.3 million people living in the U.S., equal to 68.5% of the total population, are fully vaccinated, meaning they have had their primary shots.

    So far, just 26.3 million Americans have had the updated COVID booster that targets the original virus and the omicron variants, equal to 8.4% of the overall population.

    [ad_2]

    Source link

  • China aiming for less disruptive COVID policies, reports say

    China aiming for less disruptive COVID policies, reports say

    [ad_1]

    Chinese officials are trying to quell an outcry over the death of a 3-year-old boy from a quarantined residential compound that added to public anger at anti-virus controls that have confined millions of people to their homes.

    The boy died at a hospital in Lanzhou of carbon monoxide poisoning blamed on a gas leak. His father accused health workers who were enforcing the closure of the compound of refusing to help and trying to stop him as he rushed his son to the hospital.

    The father’s account on social media prompted angry comments about the human cost of the ruling Communist Party’s “Zero COVID” strategy that has confined families to cramped apartments for weeks at a time to fight outbreaks.

    The quarantine system “is to protect life and health, not to confront those who need to be rescued with obstacles!” said a post on the popular Sina Weibo social media service.

    The ruling party is sticking to “Zero COVID” at a time when other governments are easing anti-virus controls. That has kept China’s infection numbers relatively low but disrupts business and travel.

    Residents of many parts of the Xinjiang region in the northwest were barred from leaving their homes in August and September. People in Urumqi and other cities who said they had run out of food and medicine posted appeals for help on social media.

    Public frustration has boiled over into fights with police and health workers in some places.

    The Lanzhou city government expressed “deep sorrow and regret” for the boy’s death in a statement and blamed “weak emergency response.” It said public employees who were found to have responded poorly would be “dealt with seriously.”

    The boy’s father said he tried to call an ambulance after his son collapsed Monday after a possible gas leak at home. The father wrote that he asked health workers at the compound gate for help but they told him to ask someone else and asked him to show a negative virus test. The father wrote that he wound up taking his son by taxi to a hospital, where doctors failed to revive him.

    A city government statement on its social media account said investigators found an employee at a neighborhood checkpoint told the father to call the emergency number when he asked for help.

    Lanzhou Mayor Zhang Weiwen visited the neighborhood Thursday and promised to “open up the ‘last mile’ for the masses to seek medical treatment,” the government newspaper Lanzhou Daily reported.

    The government promised to “deeply learn from the painful lessons of this accident,” the newspaper said.

    The public, companies and foreign investors are watching for signs the ruling party might ease restrictions that are weighing on the economy and make travel into and out of China cumbersome.

    The ruling party newspaper People’s Daily tried last month to dispel hopes for a quick easing, saying “Zero COVID” was working and citing health experts who said it had to stay in place.

    Despite that, stock prices of Chinese companies jumped in Hong Kong on Tuesday after a rumor circulated on social media that a “reopening committee” might be created to look at easing restrictions. Prices fell after the government failed to confirm the rumor.

    See: Alibaba, JD.com, Nio extend rally in Chinese stocks amid continued hope for relaxing COVID rules

    On Friday, share prices in Hong Kong jumped again after an official newspaper said the health ministry wants to make anti-virus measures less costly and a city with the world’s biggest iPhone factory promised to ease restrictions.

    Health experts and economists say “Zero COVID” is likely to stay in place possibly through most of 2023, due partly to the need to vaccinate millions of elderly people before Beijing can consider relaxing requirements that people who come into China must be quarantined for a week or more.

    See also: BioNTech stock surges toward 3-month high after report China agrees to approve its COVID vaccine for foreigners

    This week, access to an industrial zone in the central city of Zhengzhou that is home to the biggest factory assembling Apple Inc.’s iPhones was suspended following infections.

    The National Health Commission said this week the country needs to control outbreaks “with the minimum scale affected and the shortest time and lowest cost possible,” according to the Global Times, published by the ruling party newspaper People’s Daily.

    That is meant to “correct mistakes from overly strict measures that have caused damage to people’s properties and lives,” the Global Times reported late Thursday.
    Among other changes, train passengers bound for Beijing from the southern region of Guangxi, near Hong Kong, no longer need to submit nucleic test results, the newspaper said.

    The ruling party responded to complaints about the high cost of “Zero COVID” by switching earlier this year to a strategy that isolates buildings or neighborhoods instead of entire cities after cases found.

    Still, after outbreaks in Shanghai in March, most of the city’s 25 million people were confined to their homes for two months. More recently, families have been confined at home for weeks at a time following outbreaks.

    On Monday, visitors to Shanghai Disneyland were temporarily blocked from leaving the park as part of virus testing the city said extended to some 439,000 people. The city health agency said the guests all tested negative.

    In Zhengzhou, a city of 12.5 million people in Henan province, authorities said Thursday restrictions were being eased while the government tries to spot and isolate new cases.

    On Wednesday, access to an industrial zone adjacent to the Zhengzhou airport was suspended for one week following outbreaks.

    Thousands of employees who assemble Apple’s iPhone 14 at a factory there operated by Foxconn Technology Group left last month following complaints coworkers who fell ill didn’t receive medical help. The company later said it had imposed “closed loop management,” an official term for employees living at their workplaces and having no outside contact.

    Foxconn said the Zhengzhou factory was operating but the company and Apple haven’t responded to questions about how production and shipments might be affected.

    Authorities are focused on “restoring order to production and life” and will “strive to end this round of the epidemic as soon as possible,” said the Zhengzhou city government’s deputy secretary-general, Li Huifang, at a news conference, according to The Paper, a Shanghai news outlet.

    [ad_2]

    Source link

  • Tim Cook has been an excellent leader for Apple — these numbers prove it

    Tim Cook has been an excellent leader for Apple — these numbers prove it

    [ad_1]

    How good is a company’s chief executive officer at investing your money most efficiently? This is an important question for long-term investors. It may underline the difference between a steady long-term performer and a flash in the pan.

    And Apple Inc.
    AAPL,
    -4.24%

    now makes up 7% of the SPDR S&P 500 ETF Trust
    SPY,
    -1.03%
    ,
    the first and largest exchange-traded fund (with $360 billion in assets), which tracks the benchmark S&P 500
    SPX,
    -1.06%
    .
    That’s close to an all-time record, and the iPhone maker has a whopping 14.1% position in the Invesco QQQ Trust
    QQQ,
    -1.95%
    ,
    which tracks the Nasdaq-100 Index
    NDX,
    -1.98%
    .
    Looking at the full Nasdaq Index
    COMP,
    -1.73%
    ,
    which has 3,747 stocks, Apple takes a 13.5% position.

    Apple now makes up 7.3% of the S&P 500 by market capitalization, close to the 8% record it set late in September.


    FactSet

    This is very much an Apple stock market, with the company topping the broad indexes that are weighted by market capitalization. You are likely to be invested in the company indirectly. You also might be feeling Apple’s impact in other ways. Apple’s App Store ecosystem drives more than $600 billion in annual revenue for developers.

    Tim Cook’s tenure as Apple’s CEO has been nothing short of breathtaking when measured by the company’s financial performance. Apple is not one of the fastest-growing companies when measured by sales or earnings — it is too big for that. But its excellent stock performance has reflected Cook’s ability to deploy invested capital with improving efficiency. Cook has also been a market trendsetter in other important ways. He has Apple repurchasing $90 billion of its shares annually, setting the pace for stock buybacks in the market. Cook’s steady hand has also helped Apple withstand the market’s tech wreck and remain a stable pillar for the teetering Nasdaq Composite index generally. For all these reasons, Cook has earned a spot on the MarketWatch 50 list of the most influential people in markets

    Apple keeps improving by this important measure

    Investors in the stock market are looking for growth over the long term. The best measure of that is whether or not a company’s share price goes up or down. But Cook isn’t just managing Apple’s stock. Digging a bit deeper into the company’s actual operating performance can provide some insight into what a good job Cook has done.

    What should a corporate manager focus on? The stock price? How about the most efficient and most profitable way to provide goods and services? There are different ways to do this, and Apple has focused on quality, reliability and excellent service to build customer loyalty.

    Apple’s commitment can be experienced by anyone who calls the company for customer service. It is easy to get through to a well-trained representative who will solve your problem. How many companies can say that at a time when it seems many companies cannot even handle answering the phone? 

    Getting back to actual performance, Cook took over as Apple’s CEO in August 2011 when Steve Jobs stepped down. The chart below shows the company’s quarterly returns on invested capital from the end of 2010 through September 2022.

    Apple’s returns on invested capital have increased markedly over the past six years.


    FactSet

    A company’s return on invested capital (ROIC) is its profit divided by the sum of the carrying value of its common stock, preferred stock, long-term debt and capitalized lease obligations. ROIC indicates how well a company has made use of the money it has raised to run its business. It is an annualized figure, but available quarterly, as used in the chart above.

    The carrying value of a company’s stock may be a lot lower than its current market capitalization. The company may have issued most of its shares long ago at a much lower share price than the current one. If a company has issued shares recently or at relatively high prices, its ROIC will be lower.

    A company with a high ROIC is likely either to have a relatively low level of long-term debt or to have made efficient use of the borrowed money.

    Among companies in the S&P 500 that have been around for at least 10 years, Apple placed within the top 20 for average ROIC for the previous 40 reported fiscal quarters as of  Sept. 1.

    As you can see on the chart, Apple’s ROIC has improved dramatically over the past five years, even as the wide adoption of the company’s products and services has led to an overall slowdown in sales growth.

    A quick comparison with other giants in the benchmark index

    It might be interesting to see how Apple stacks up among other large companies, in part because some businesses are more capital-intensive than others. For example, over the past four quarters, Apple’s ROIC has averaged 52.9%, while the average for the S&P 500 has been a weighted 12.1%, by FactSet’s estimate.

    Here are the 10 companies in the S&P 500 reporting the highest annual sales for their most recent full fiscal years, with a comparison of average ROIC over the past 40 reported quarters:

    Company

    Ticker

    Annual sales ($mil)

    Avg. ROIC – 40 quarters

    Total Return – 10 Years

    Walmart Inc.

    WMT,
    -0.02%
    $572,754

    11.0%

    142%

    Amazon.com Inc.

    AMZN,
    -3.06%
    $469,822

    6.8%

    693%

    Apple Inc.

    AAPL,
    -4.24%
    $394,328

    33.0%

    721%

    CVS Health Corp.

    CVS,
    +1.03%
    $291,935

    6.8%

    161%

    UnitedHealth Group Inc.

    UNH,
    +0.03%
    $287,597

    13.7%

    1,031%

    Exxon Mobil Corp.

    XOM,
    +1.36%
    $280,510

    9.9%

    85%

    Berkshire Hathaway Inc. Class B

    BRK.B,
    -1.94%
    $276,094

    8.2%

    233%

    McKesson Corp.

    MKC,
    -0.61%
    $263,966

    6.6%

    353%

    Alphabet Inc. Class A

    GOOGL,
    -4.07%
    $257,488

    16.6%

    405%

    Costco Wholesale Corp.

    COST,
    +0.57%
    $226,954

    16.2%

    558%

    Source: FactSet

    Among the largest 10 companies in the S&P 500 by annual sales, Apple takes the top ranking for average ROIC over the past 10 years, while ranking second for total return behind UnitedHealth Group Inc.
    UNH,
    +0.03%

    and ahead of Amazon.com Inc.
    AMZN,
    -3.06%
    .
    UnitedHealth has been able to remain at the forefront of managed care during the period of transition for healthcare in the U.S., in the wake of President Barack Obama’s signing of the Affordable Care Act into law in 2010.

    Here’s a chart showing 10-year total returns for Apple, UnitedHealth Group, Amazon and the S&P 500:


    FactSet

    Apple is only slightly ahead of Amazon’s 10-year total return. But what is so striking about this chart is the volatility. Apple has had a smoother ride. During the bear market of 2022, Apple’s stock has declined 18%, while the S&P 500 has gone down 20%, the Nasdaq has fallen 32% (all with dividends reinvested) and Amazon has dropped 45%.

    The broad indexes would have fared even worse so far this year without Apple.

    TO SEE THE FULL MARKETWATCH 50 LIST CLICK HERE

    [ad_2]

    Source link

  • Hospitalizations on the rise in New York City as new COVID strains spread rapidly

    Hospitalizations on the rise in New York City as new COVID strains spread rapidly

    [ad_1]

    Hospitalizations are rising again in New York City with the spread of new COVID-19 subvariants that are better at evading immunity. Cases of flu and respiratory syncytial virus, or RSV, are also increasing.

    State data show about 1,100 patients hospitalized with COVID as of Oct. 24, up from 750 in mid-September, as the New York Times reported. Case numbers have held steady, although with many people testing at home where data are not being collected, those numbers are not reliable.

    Data from the Centers for Disease Control and Prevention show that the omicron sublineages named BQ.1 and BQ.1.1 accounted for 42.5% of all cases in the New York region in the week through Oct. 29, up from 37% the previous week.

    That was more than the BA.5 omicron subvariant, which accounted for 35.7% of new cases in the New York region in the latest week. The two sublineages were not even registering as recently as three weeks ago, demonstrating just how fast they are spreading.

    Experts are also concerned about a nationwide surge in RSV, which can cause breathing difficulties in small children and older adults and for which there is currently no vaccine.

    There was good news from Pfizer Inc., however, which said Tuesday that data from a late-stage trial of an RSV vaccine had proved effective in preventing severe illness in children up to 6 months old.

    The Phase 3 trial found that the vaccine, given to pregnant mothers, achieved vaccine efficacy of 81.8% in infants from birth through the first 90 days of life. The trial found efficacy of 69.4% through the first 6 months of life.

    Pfizer
    PFE,
    +3.14%

    said it expects to make its first U.S. regulatory application for the vaccine by the end of 2022 and to follow on with other regulatory bodies. It will also submit the results of the trial for peer review in a scientific journal.

    The daily U.S. average for new COVID cases stood at 37,665 on Monday, according to a New York Times tracker, which was flat as compared with two weeks ago. The daily average for hospitalizations was up 2% to 27,184, while the daily average for deaths was down 3% to 348. 

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Apple 
    AAPL,
    -1.75%

    supplier Foxconn
    2317,

    said Tuesday it has quadrupled bonuses for workers at its Zhengzhou plant in central China as it seeks to quell discontent over COVID restrictions and retain staff at the giant iPhone manufacturing site, Reuters reported. Daily bonuses for employees, who are part of a Foxconn unit responsible for making electronics including smartphones, have been raised to 400 yuan ($55) a day for November from 100 yuan, according to the official WeChat account of Foxconn’s Zhengzhou plant. The move comes after workers fled the site over the weekend to avoid COVID curbs after complaining about their treatment and provisions via social media.

    Workers at the world’s biggest assembly site for Apple’s iPhones walked out as Foxconn has struggled to contain a COVID-19 outbreak. The chaos highlights the tension between Beijing’s rigid pandemic controls and the urge to keep production on track. Photo: Hangpai Xinyang/Associated Press

    • The Wall Street Journal reported Tuesday that Hong Kong stocks appeared to be rallying after an anonymous post on Chinese social media suggested that the government may intend to soften pandemic-related restrictions beginning in March. Other outlets also reported on the rumor. American depositary receipts for Chinese companies surged on the news.

    See: Alibaba and Nio among Chinese stocks surging as hopes build about potential reopening

    • Pfizer’s COVID antiviral Paxlovid brought in $7.5 billion in sales in the third quarter of the year, compared with a FactSet consensus of $7.6 billion. The drug company also reiterated guidance for Paxlovid revenues in 2022, saying it still expects $22 billion in sales for the year. The FactSet consensus is $22.5 billion. Pfizer raised its full-year revenue guidance for the company’s Comirnaty COVID vaccine by $2 billion to $34 billion. The guidance includes doses expected to be delivered in fiscal 2022, primarily under contracts signed as of mid-October.

    • AstraZeneca PLC’s
    AZN,
    +1.77%

    AZN,
    +0.90%

    COVID vaccine Vaxzevria has been granted full marketing authorization in the European Union, Dow Jones Newswires reported. The Anglo-Swedish pharmaceutical giant said Vaxzevria has been shown to be effective against all forms of the virus. Vaxzevria was originally granted conditional marketing authorization due to the urgency of the COVID-19 pandemic, it said.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 630.6 million on Monday, while the death toll rose above 6.59 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 97.5 million cases and 1,070,429 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 226.9 million people living in the U.S., equal to 68.4% of the total population, are fully vaccinated, meaning they have had their primary shots.

    So far, just 22.8 million Americans have had the updated COVID booster that targets the original virus and the omicron variants, equal to 7.3% of the overall population.

    [ad_2]

    Source link

  • Biden seeks to drive contrast with GOP in Florida with 1 week until midterms

    Biden seeks to drive contrast with GOP in Florida with 1 week until midterms

    [ad_1]

    Washington — President Biden is heading to Florida to underline the contrast between the Democratic and Republican agendas, blasting the GOP over proposals to undo prescription drug price caps and change Social Security and Medicare.

    Mr. Biden’s trip Tuesday will include taxpayer-funded remarks in Hallandale Beach, where the White House said he would highlight Republicans’ “very different vision” for America. Also on Mr. Biden’s schedule are a fundraiser for Florida gubernatorial candidate Charlie Crist and a rally for the state’s Democratic Party, including Senate candidate Val Demings.

    The visit to Florida, where Democrats are trailing in both the Senate and the gubernatorial races, may appear counterintuitive just one week before polls close in the midterm elections when so many other races are tighter. Yet Biden allies say it exemplifies the president’s efforts to go where he can be helpful — Florida Democrats are hoping Mr. Biden can help boost base turnout — but also to drive a message that vulnerable Democrats can amplify nationwide.

    The president has avoided appearing with some of the Democrats’ most embattled candidates, including Georgia Sen. Raphael Warnock and Arizona Sen. Mark Kelly, but his aides insist he can be helpful from afar by talking about GOP policies they believe voters find objectionable. Mr. Biden is set to campaign in New Mexico on Thursday, California on Friday and Pennsylvania on Saturday.

    Mr. Biden has seized on Florida Sen. Rick Scott’s February proposal to sunset all federal legislation after five years, which the president says would require Congress to reauthorize Medicare and Social Security, as emblematic of what he’s termed the “ultra-MAGA” agenda Democrats are running against.

    Besides Scott’s plan, the White House said Mr. Biden would emphasize other GOP proposals that affect older Americans, including raising the retirement age and repealing Medicare’s ability to negotiate drug prices with manufacturers and the $2,000-a-year cap on out-of-pocket drug costs included in Democrats’ August health care and climate law.

    [ad_2]

    Source link

  • New omicron subvariants accounted for more cases in New York region in latest week than BA.5, CDC data shows

    New omicron subvariants accounted for more cases in New York region in latest week than BA.5, CDC data shows

    [ad_1]

    The omicron sublineages named BQ.1 and BQ.1.1 continued to spread in the U.S. in the week through Oct. 29, accounting for 27.1% of new cases nationwide, according to Centers for Disease Control and Prevention data.

    The two accounted for 42.5% of all cases in the New York region, which includes New Jersey, Puerto Rico and the Virgin Islands, up from 37% the previous week. That was more than the BA.5 omicron subvariant, which accounted for 35.7% of new cases in the New York area in the latest week.

    The BA.5 omicron subvariant accounted for 49.6% of all U.S. cases, the data show.

    BQ.1 and BQ.1.1 were included in BA.5 variant data as recently as three weeks ago, because their numbers were too small to break out. BQ.1 was first identified by researchers in early September and has been found in the U.K. and Germany, among other places.

    Last week, the World Health Organization said that BQ.1 and another sublineage dubbed XBB do not appear to have immune-escape mutations that warrant being designated as variants of concern. However, BA.5 is still a variant of concern that is being closely monitored, said a statement from the WHO’s Technical Advisory Group on SARS-CoV-2 Virus Evolution.

    Workers in a manufacturing facility that assemble Apple Inc.’s
    AAPL,
    -1.66%

    iPhone in the Chinese city of Zhengzhou appear to have left to avoid COVID-19 curbs, with many traveling on foot for days after an unknown number of employees were quarantined in the facility after a virus outbreak, the Associated Press reported. 

    Videos circulating on Chinese social media platforms showed people who are allegedly Foxconn workers climbing over fences and carrying their belongings down a road.

    Separately, visitors to Shanghai Disneyland were left stranded at the park on Monday after the resort halted operations to comply with COVID-19 restrictions amid a new outbreak of the virus.

    In the U.S., known cases of COVID are continuing to ease and now stand at their lowest level since mid-April, although the true tally is likely higher given how many people overall are testing at home, where data are not being collected.

    The daily average for new cases stood at 36,869 on Sunday, according to a New York Times tracker, down 2% from two weeks ago. The daily average for hospitalizations was up 3% to 27,415, while the daily average for deaths was down 6% to 352. 

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • With a downcast earnings season passing the halfway mark, results from financial-technology companies and vaccine makers will arrive this week amid questions about consumer spending as well as demand for COVID drugs, MarketWatch’s Bill Peters reported. Pfizer Inc.
    PFE,
    -1.82%

    will report earnings on Tuesday, followed by Moderna Inc.
    MRNA,
    -0.47%

    on Thursday. Analysts will have their eye on the state of COVID-19 vaccine and treatment sales and on what executives are anticipating for the full year, as they prepare for a private market for COVID medications and as more people shrug off the pandemic. Pfizer executives, during a call last week, said they intended to charge between $110 and $130 for a single-dose vial of the vaccine for U.S. adults when government purchases end. But they said they believe anyone who has health insurance shouldn’t have to pay anything out of pocket.

    The FDA authorized newly modified COVID-19 boosters to target the latest versions of the omicron variant. But as WSJ’s Daniela Hernandez explains, a key part of the decision-making process was changed with these new shots. Photo: Laura Kammermann

    • A number of young children are being hospitalized because of respiratory syncytial virus, or RSV, and it’s happening at an unusual time of year and among older children than in years past, MarketWatch’s Jaimy Lee reported. COVID may be a contributing factor, in part because many children were not exposed to RSV last season and also because a prior COVID infection or exposure may change the way a baby’s immune system responds to RSV and may lead to more severe illness from an RSV infection, according to Asuncion Mejias, a principal investigator with the Center for Vaccines and Immunity at the Research Institute at Nationwide Children’s Hospital in Columbus, Ohio.

    • On Saturday, more than 3,000 people took part in the first Pride march in South Africa since the COVID pandemic , celebrating the LGBT community and defying a U.S. warning of a possible terror attack in the area, the AP reported. The U.S. government this week warned of a possible attack in the Sandton part of Johannesburg, where the march took place. The South African government expressed concern that the U.S. had not shared enough information to give credibility to the alleged threat. Police said all measures had been taken to ensure safety in the area.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 630.2 million on Monday, while the death toll rose above 6.58 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 97.5 million cases and 1,070,266 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 226.9 million people living in the U.S., equal to 68.4% of the total population, are fully vaccinated, meaning they have had their primary shots.

    So far, just 22.8 million Americans have had the updated COVID booster that targets the original virus and the omicron variants, equal to 7.3% of the overall population.

     

    [ad_2]

    Source link

  • Opinion: Why pre-sports evaluation forms for girls worry me — and should concern you, too | CNN

    Opinion: Why pre-sports evaluation forms for girls worry me — and should concern you, too | CNN

    [ad_1]

    Editor’s Note: Megan Ranney, MD, MPH, is the deputy dean at the School of Public Health at Brown University and a professor of emergency medicine at the University’s Warren Alpert Medical School. The views expressed in this commentary are her own. Read more opinion on CNN.



    CNN
     — 

    As a physician, a public health professional and a parent of a teenage girl, I’ve been following news about a Florida school district’s decision to digitize kids’ school athletic records with interest – and with concern.

    What should be a simple decision about medical best practice has been turned into a Gordian knot of not just health, but also policy, politics, technology and bodily autonomy.

    Being active is obviously important for kids, in general. We should do everything we can to encourage all youth to engage in physical activity, whether through organized sports or informal activity. Although, traditionally, women were less likely to be competitive athletes, the number of US high school athletes who identify as female has increased more than 10-fold over the last five decades. This growth deserves to be supported.

    For kids of all genders to safely participate in competitive sports, a consortium of medical organizations have agreed on a standardized pre-sports physical screening and exam. The exact rules and regulations differ between states, but the overarching goal of a pre-sports physical is to allow physicians (or other appropriate clinicians) to identify and then mitigate potential harms from youth sports participation.

    The pre-sports evaluation form used by the Florida High School Athletic Association, and by extension the Palm Beach County School District, includes screening for everything from family history of cardiac disorders to concussions, depression and eating disorders. These questions are included for good reason. Competitive athletes of all genders are prone to energy deficiency, whether due to disordered eating or due to excessive energy use during practices. This energy deficiency can cause long-lasting harm, especially for adolescents.

    When the energy deficiency is accompanied by amenorrhea (lack of a period), it is particularly worrisome, as the metabolic and endocrine side-effects can weaken athletes’ bones, increase the risk of stress fractures and increase the risk of long-term osteoporosis. It is, therefore, medically appropriate to ask athletes about signs of disordered eating, amenorrhea, and other signs of physical danger when deciding whether an athlete is safe to practice and compete. This is also the reason the screening form also includes four questions for “females only” about menstruation.

    However, there is a big difference between a physician or other trained healthcare professional asking these questions in private, as part of a clinical assessment, and the physician sharing all the details with third parties.

    That some states may share the full physical and screening exam – including information about youth athletes’ menstrual cycles – with school districts, state officials and third-party digital record-keeping companies is, to me, deeply worrisome. The strictures of the post-Dobbs world, the reality of today’s tech world and the suggestive examples of other instances where these intersections have left women and girls vulnerable could put parents and doctors in an untenable position.

    From a purely medical perspective, the pre-participation exam forms approved by the American Academy of Family Physicians, American Academy of Pediatrics, American College of Sports Medicine, American Medical Society for Sports Medicine, American Orthopaedic Society for Sports Medicine, and American Osteopathic Academy of Sports Medicine, specify that only the final decision (e.g., whether or not a patient is cleared for sports, and whether there are restrictions) should be shared with a school district. They specifically comment that the medical exam and screening questions should remain with the evaluating clinician or physician.

    This guidance reflects the tremendous importance of protecting the privacy of the patient-physician relationship. The confidentiality of clinical discussions is important in general, but all the more so for adolescents. And reproductive and gynecologic care, including discussions about menstruation, are appropriately considered to be even more private than, say, a lung or heart or knee exam.

    But my concern about the reported sharing of data goes beyond fears of impairing the patient-physician relationship. The current social, political and technological environment creates a perfect storm for this information-sharing to endanger youth in a myriad of ways.

    First, laws regarding reproductive health, gender and abortion are quickly being rewritten nationwide. In Texas and Oklahoma, those states effectively offer a bounty to anyone who reports a suspected abortion. In other states, being transgender can result in exclusion from organized sports. One could easily imagine a world in which – if school officials or coaches are expected to follow an athlete’s menstrual cycle – some youth would be reported up the chain (accurately or inaccurately) for missed periods. For some youth, this reporting could result in inappropriate and invasive gynecologic exams. For other youth, this could result in them and their parents being charged with a crime. And knowing about a kid’s periods potentially puts schools in a position of liability.

    Second, the security of a third-party software system (such as that being used by districts in Florida) is often dubious. While I can’t judge the level of security particular software program being used in Florida, many of us have previously discussed our concerns about poorly designed, poorly protectedperiod tracking apps.Cyber-hacking of electronic health records is on the rise. Even the largest, most security-conscious health care organizations are at risk, and data from reproductive health organizations has been specifically targeted and shared. As soon as we share menstrual data with a digital application, we must also worry about its being accessed by those with nefarious intentions.

    I doubt that most school systems are ready for these legal and security risks.

    Finally, as a mother of a teenager (and a former high school athlete, myself) I cringe at the thought of a coach – even with the best of intentions! – following a child’s menstrual cycle for signs of missed periods. Even in my state (which protects abortion as healthcare, albeit with parental consent), this kind of tracking would be embarrassing at best and invasive at worst. And my worries would be far greater if I were in a state that limited my own and my children’s reproductive rights.

    I am glad that Palm Beach County has reconsidered this dangerous policy and asked that questions about menstrual history be removed from Florida’s pre-sports evaluation form. Here’s hoping the Florida High School Athletic Association listens and does what’s right for the sake of kids, parents, coaches and schools.

    [ad_2]

    Source link

  • COVID-19 may be to blame for the surge in RSV illness among children. Here’s why.

    COVID-19 may be to blame for the surge in RSV illness among children. Here’s why.

    [ad_1]

    A number of young children are being hospitalized because of respiratory syncytial virus, or RSV, and it’s happening at an unusual time of year and among older children than in years past.

    RSV infections and related emergency-room visits and hospitalizations are nearing seasonal peaks in some U.S. regions, according to the Centers for Disease Control and Prevention.

    But the current RSV outbreak is different from previous outbreaks in several ways: It’s happening in the fall rather than the winter (RSV commonly peaks after the holidays, starting in late December); older children and not just infants are being hospitalized; and cases are occurring that are more severe than in previous years. And this year, RSV is circulating at the same time as COVID, influenza, and other viruses like the biennial enterovirus, which was behind a rise in pediatric hospitalizations earlier this fall. 

    “The theory is that everyone’s now back together, and this is a rebound phenomenon,” said Jeffrey Kline, a physician and associate chair of research for emergency medicine at Wayne State University School of Medicine in Detroit.

    Kline runs a national surveillance network that gathers data about viral infections from about 70 hospitals, including four pediatric hospitals. He says those data show that 318 children were hospitalized with acute respiratory illness brought on by RSV in the week starting Oct. 9, compared with 45 hospitalizations in the week starting July 25.  

    “If we think about the relative increase — ninefold increase — that’s not nothing, especially in the pediatric [emergency departments],” Kline said. “Holy mackerel.”


    Source: CDC

    The U.S. saw a massive spike in RSV cases in the summer of 2021, after masking and social distancing resulted in a lull in infections the previous year. Even with that spike, fewer young children — 2-, 3-, and 4-year-olds — have been exposed to RSV than in a normal year. Most children have usually had at least one RSV infection by the time they are 2 years old, and as children get older, RSV becomes less worrisome, according to the CDC. Infants are at higher risk for severe disease brought on by RSV because babies have more immature immune responses than older children and because infants younger than 6 months of age breathe exclusively through their noses and cannot breathe through their mouths if they are congested.

    “Age by itself is a risk factor for more severe disease, meaning that the younger babies are usually the ones that are sick-sick,” said Asuncion Mejias, a principal investigator with the Center for Vaccines and Immunity at the Research Institute at Nationwide Children’s Hospital in Columbus, Ohio. Now, she added, “we are seeing also older kids, probably because they were not exposed to RSV the previous season.”

    But there’s another reason that COVID may be worsening some RSV infections in the youngest children. Mejias is studying whether a prior COVID infection or exposure somehow changes the way a baby’s immune system responds to RSV and whether it may lead to more severe illness from an RSV infection. 

    “That is something to work on and understand,” she said. 

    For now, however, worries are tied to the possibility of a “tripledemic” of COVID, influenza, and RSV as the U.S. heads into what is expected to be a complicated season for respiratory infections. Stat News reported in mid-October that flu season is already underway, and the CDC said this week that this year’s flu activity may have “atypical timing and intensity.” 

    COVID itself remains a threat, as well. There are still more children being hospitalized with COVID than with RSV, Kline said, and some kids are getting sick from both viruses at the same time. About 5% of children are thought to test positive for both RSV and COVID, and 60% of the children in that group were hospitalized, according to Kline’s surveillance network. 

    “All these things are going on all at once right now,” said Alex Frost, managing director for StudyMaker, which is providing software infrastructure to the network. “But the shape of pediatric cases that are showing up in the emergency room is different than it used to be.”

    [ad_2]

    Source link

  • WHO panel says no evidence yet that new omicron subvariants are more dangerous than others that are circulating

    WHO panel says no evidence yet that new omicron subvariants are more dangerous than others that are circulating

    [ad_1]

    The omicron sublineages named BQ.1 and XBB do not appear to have immune escape mutations that warrant being designated as variants of concern, a World Health Organization advisory panel said Friday.

    The decision will be reassessed regularly to ensure there is no change that might warrant a new designation, said the statement.

    As of Oct. 25, the XBB and XBB.1 lineages had been detected in 35 countries, according to a WHO weekly update from Thursday. The two are BA.2.10.1 and BA.2.75 recombinants, which were found in 26 countries in the previous week.

    “There has been a broad increase in prevalence of XBB in regional genomic surveillance, but it has not yet been consistently associated with an increase in new infections,” the panel wrote. However, early evidence does suggest a higher reinfection risk compared with other circulating omicron variants.

    BQ.1 is a sublineage of BA.5, which remains dominant globally, accounting for 77.1% of sequences forwarded to a centralized database in the week through Oct. 23. BQ.1 has been found in 65 countries.

    “While there are no data on severity or immune escape from studies in humans, BQ.1* is showing a significant growth advantage over other circulating Omicron sublineages in many settings, including Europe and the US, and therefore warrants close monitoring,” said the panel.

    The real risk of the variants depends on the level of immunity in a given region, it added. And with waning immune response from initial waves of omicron infection, and further evolution of omicron variants, “it is likely that reinfections may rise further,” said the statement.

    Read now: COVID-19 may be to blame for the surge in RSV illness among children. Here’s why.

    In the U.S., known cases of COVID are continuing to ease and now stand at their lowest level since mid-April, although the true tally is likely higher given how many people overall are testing at home, where the data are not being collected.

    The daily average for new cases stood at 37,412 on Thursday, according to a New York Times tracker, down 3% from two weeks ago. The daily average for hospitalizations was up 1% at 27,002, while the daily average for deaths is down 5% to 358. 

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Gilead Sciences Inc.
    GILD,
    +12.92%

    said sales of its COVID treatment Veklury, formerly known as remdesivir, fell 52% to $925 million in the third quarter, driven by lower rates of COVID-19-related hospitalizations compared to the third quarter of 2021.” Last month, Gilead said the World Health Organization expanded its guidance to recommend remdesivir for treatment of patients with severe symptoms.

    • The pandemic devastated poor children’s well-being, not just by closing their schools, but also by taking away their parents’ jobs, sickening their families and teachers, and adding chaos and fear to their daily lives, the Associated Press reported, citing an analysis of test scores that was shared on an exclusive basis. The analysis found the average student lost more than half a school year of learning in math and nearly a quarter of a school year in reading—with some district averages slipping by more than double those amounts, or worse. Online learning played a major role, but students lost significant ground even where they returned quickly to schoolhouses, especially in math scores in low-income communities.

    • Optimism among U.S. companies in China has hit record low levels, an annual survey showed on Friday, as competitive, economic, and regulatory challenges compound the stresses already imposed by Beijing’s ongoing zero-COVID policies, Reuters reported. Just 55% of 307 companies surveyed by the American Chamber of Commerce in Shanghai and consulting firm PwC China described themselves as optimistic about the five-year business outlook. The reading is the lowest in the survey’s 23-year history and worse than in 2020, when COVID first surfaced, and during the trade standoff between Beijing and Washington in 2019.

    • The Chinese city of Shanghai has ordered mass testing on all 1.3 million residents of its downtown Yangpu district and is confining them to their homes at least until results are known, the AP reported. The demand is an echo of measures ordered over the summer that led to a two-month lockdown of the entire city of 25 million that devastated the local economy, prompting food shortages and rare confrontations between residents and the authorities.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 629.6 million on Friday, while the death toll rose above 6.58 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 97.4 million cases and 1,070,064fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 226.9 million people living in the U.S., equal to 68.4% of the total population, are fully vaccinated, meaning they have had their primary shots.

    So far, just 22.8 million Americans have had the updated COVID booster that targets the original virus and the omicron variants, equal to 7.3% of the overall population.

    [ad_2]

    Source link

  • U.S. could face

    U.S. could face

    [ad_1]

    The U.S. could very well face what has been dubbed a “tripledemic” this winter, with cases of COVID-19, the flu and a virus called respiratory syncytial virus (RSV) surging at the same time. 

    Cases of RSV are rising quickly in young children, who typically contract the virus by the time they’re three, but who were shielded from it and other viruses during lockdown periods. 

    “Pediatric ICUs around the country, many parts of it, are full,” said CBS News medical contributor Dr. David Agus. Most hospitalizations now are related to influenza and RSV, not COVID-19, he added.  

    The simultaneous increase in cases of three distinct viruses comes as more professionals are leaving the health care field for work that either pays better or is less physically and emotionally draining, which could further threaten the nation’s strained health care system.

    “I’m concerned that hospitals, health care providers are going to be overwhelmed,” said CBS News medical contributor and Kaiser Health News editor-at-large Dr. Celine Gounder. “We’re looking at very high rates of both flu and RSV, so probably something around like 35,000 hospitalizations per week just from those two conditions.”

    Of course, COVID-19 is still around, too. “Are we going to be prepared, are we going to have the beds? I’m really concerned about that,” Gounder said. 

    Unmanned hospital beds

    There is now a vaccine available for RSV, a common respiratory virus that causes cold-like symptoms but which can be serious in infants and older adults, according to the Centers for Disease Control and Prevention. 

    Lately, a spike in RSV cases among very young children has overwhelmed pediatric hospitals. Little kids are especially susceptible to developing severe symptoms because their immune systems are undeveloped and their airways are smaller than those of adults, making it harder to breathe when inflamed. 

    The health care system is also grappling with a reduced labor force following an exodus of health care workers from the field during the pandemic, largely due to burnout. That means that even more work falls on the laps of the nurses, doctors and administrative and support staff who remain in the industry. 

    Some 330,000 medical professionals dropped out of the labor force in 2021 according to health care commercial intelligence company Definitive Healthcare. 

    “It’s an even more difficult situation, [with] even more understaffing, so then even more people get burned out and leave,” Gounder said.


    Health care workers see rise in physical, verbal assaults from COVID patients

    02:13

    Seeking a better work-life balance

    Some of the physicians, nurse practitioners, physician assistants and other providers left their jobs to retire early, while others decided to seek out administrative work and stop seeing patients.

    “So it’s all different kinds of ways of reducing that burnout of having a better work-life balance which, frankly, over the last couple of years, it’s been really hard on people,” Gounder said. 

    Gounder said she’s already seeing the impact of limited staff on patients seeking care at Bellevue Hospital in New York City.

    “Patients are sitting in the emergency room for a day or two waiting for a bed, because it’s not just about having the physical bed — you need to have the doctors, the nurses, the other staff to man that bed,” she said. 

    “The whole system is really clogged up right now,” she added. 

    Workers across diverse fields left jobs in search of better wages and working conditions during the so-called “Great Resignation.”

    There’s no clear-cut solution or obvious way to lure more professionals back to the medical field, and though higher wages wouldn’t hurt, better pay alone won’t fix the issue, according to Gounder. 

    “I think people are valuing their time in a whole different way now and I do think it would require really rethinking the business model of health care, really changing how we structure health care, how we deliver it, who provides it,” she said. “I’m somewhat skeptical that we’re going to make those changes.” 

    [ad_2]

    Source link

  • Almost three years into the pandemic, Chinese city of Wuhan is again in partial lockdown to stem latest outbreak of cases

    Almost three years into the pandemic, Chinese city of Wuhan is again in partial lockdown to stem latest outbreak of cases

    [ad_1]

    Almost three years since the start of the coronavirus pandemic and the Chinese city of Wuhan is again in partial lockdown, as it sticks with a strict zero-COVID policy to stem the current outbreak.

    Roughly 800,000 people in one district of the city in central China have been ordered to stay at home until Sunday, Reuters reported. Wuhan counted about 20 to 25 new COVID cases a day this week, while China overall reported more than 1,000 new cases on Thursday. That was enough to trigger lockdowns or restrictions in other cities, including Xining in the northwest and Guangzhou in the south.

    As of Oct. 24, 28 cities were implementing varying degrees of lockdown measures, with around 207.7 million people affected in regions responsible for around 25.6 trillion yuan ($3.55 trillion) of China’s gross domestic product, according to Nomura. That’s nearly a quarter of China’s 2021 economic output.

    The World Health Organization’s weekly epidemiological update, meanwhile, shows cases and fatalities are still falling across the world. The global case tally was down 15% in the week through Oct. 23 from the previous week. The number of deaths fell 13% to just over 8,500.

    The highest number of new weekly cases came from Germany at 498,787, followed by France, at 307,610; China at 285,348; and the U.S. at 255,116. Experts are expecting the winter months to bring a fresh wave of cases as people gather indoors in the colder weather.

    As it has for some months, the WHO cautioned that the numbers may be undercounted, as many countries have pulled back on testing, resulting in fewer tests and fewer positive readings.

    The BA.5 omicron subvariant remains dominant around the world, accounting for 77.1% of sequences forwarded to a centralized database, the agency said.

    “BA.2, BA.4 and BA.5 and their various subvariants have in many cases acquired the same mutations at the same position, indicating convergent evolution,” said the WHO.

    It explained that convergent evolution means the independent genetic adaptation of two or more different variants at the same genomic position, i.e., the same nucleotide or amino acid change is observed in multiple variants, with these variants not being direct descendants of each other.

    “Areas of convergent evolution point to a potential role in the adaptation and further evolution of the virus,” said the update.

    As of Oct. 25, the XBB and XBB.1 lineages have been detected in 35 countries. The two are BA.2.10.1 and BA.2.75 recombinants, which were found in 26 countries in last week’s report.

    The BQ.1 and its lineages have been found in 65 countries. BQ.1 and BQ.1.1 are BA.5 lineages and accounted for about 16.6% of new U.S. cases in the week through Oct. 22, according to data from the Centers for Disease Control and Prevention. The two were barely registering just a few weeks ago and were included in BA.5 variant data. BQ.1 was first identified by researchers in early September and has been found in the U.K. and Germany, among other places. The CDC is updating the numbers every Friday.

    The two are spreading fast in the New York region, which includes New Jersey, Puerto Rico and the Virgin Islands, and accounted for almost 30% of new cases in the same week, CDC data shows.

    In the U.S., known cases of COVID are continuing to ease and now stand at their lowest level since mid-April, although the true tally is likely higher given how many people overall are testing at home, where the data are not being collected.

    See also: A common virus is putting more children in the hospital than in recent years

    The daily average for new cases stood at 37,615 on Wednesday, according to a New York Times tracker, down 4% from two weeks ago. The daily average for hospitalizations was flat at 26,792, while the daily average for deaths is down 5% to 361.

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Qatar will drop most of its coronavirus restrictions beginning Nov. 1, just before it hosts the 2022 FIFA World Cup, the Associated Press reported. Qatar’s Health Ministry made the announcement Wednesday. In a statement, it said that PCR or rapid-antigen test results would not be required for those flying into the country. It also dropped a requirement to register for the country’s Ehteraz contract-tracing app. However, it’s mandatory to use the app to enter healthcare facilities in Qatar.

    • Fourteen Mississippi residents have been arrested on criminal charges related to a conspiracy to fraudulently obtain government funds through a federal program for small businesses, the U.S. Department of Justice announced Wednesday, the AP reported separately. All are charged with conspiracy, illegal financial transactions and wire fraud by applying for loans through the Payroll Protection Program. The loans were dispersed by the U.S. Small Business Administration early on during the COVID pandemic to prevent businesses from failing.

    China’s leader Xi Jinping opened the Communist Party congress in Beijing with a defense of his 10 years in power and a bid for a third five-year term. By staying in power, he would break succession norms established to prevent a return to a Mao-style dictatorship. Photo: Mark Schiefelbein/AP

    • LabCorp
    LH,
    -6.21%

    shares tumbled 6% Thursday after the diagnostics company said revenue in the third quarter of 2022 came in lower than expected as fewer people got PCR or antigen tests for COVID. Labcorp had earnings of $352.8 million, or $3.90 per share, in the third quarter of 2022, down from $587.3 million, or $6.05 per share, in the same quarter a year ago. Adjusted earnings per share were $4.68, against a FactSet consensus of $4.09. The company’s revenue was $3.6 billion for the quarter. That’s down from $4.0 billion in revenue in the third quarter of 2021. The FactSet consensus was $3.9 billion.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 629.1 million on Thursday, while the death toll rose above 6.58 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 97.3 million cases and 1,069,449 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 226.6 million people living in the U.S., equal to 68.2% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 111.4 million have had a booster, equal to 49.1% of the vaccinated population, and 26.8 million of those who are eligible for a second booster have had one, equal to 40.6% of those who received a first booster.

    So far, just 19.4 million Americans have had the updated COVID booster that targets the original virus and the omicron variants that have been dominant in the U.S. and around the world for months.

    [ad_2]

    Source link

  • Health insurance premiums at work didn’t rise in 2022 amid soaring inflation, but the good times won’t last | CNN Politics

    Health insurance premiums at work didn’t rise in 2022 amid soaring inflation, but the good times won’t last | CNN Politics

    [ad_1]



    CNN
     — 

    Even though the price of gas, groceries and other essentials shot up in 2022, health care premiums for employer-sponsored coverage remained essentially flat, according to a survey released Thursday.

    Job-based policies for families cost an average of roughly $22,500 in 2022, with workers contributing an average of about $6,100, the Kaiser Family Foundation Employer Health Benefit Survey found. That is basically the same as last year.

    The average cost of single policies was just over $7,900 for this year, with employees responsible for about $1,350.

    Unlike in previous years, premium growth trailed behind the increases in inflation and workers’ wages, which came in at 8% and 6.7%, respectively. That’s because the cost of coverage is typically set months in advance – before inflation really took off.

    Also, utilization of health care services remained low in 2021, so employers that fund their own health plans didn’t spend as much as anticipated, which allowed them to keep premiums steady this year, said Matthew Rae, associate director for the Program on the Health Care Marketplace at Kaiser.

    But workers can expect to feel the sting of inflation when they enroll in coverage for next year, which is happening now at many companies.

    “Employers are already concerned about what they pay for health premiums, but this could be the calm before the storm, as recent inflation suggests that larger increases are imminent,” said Drew Altman, Kaiser’s chief executive officer.

    Other surveys show that premiums and out-of-pocket costs are expected to increase in 2023 at a faster rate than in recent years due to inflation. Hospitals, doctors and other providers are feeling the pricing pressure. Their costs for labor, particularly nurses and service staff, and supplies have increased sharply due to inflation and demand. So they are pushing insurers to raise their reimbursement rates when contracts are up for renewal.

    Nearly 159 million non-elderly people are covered by employer-sponsored health insurance, according to Kaiser.

    For this year, deductibles only inched up. The average annual deductible stands at roughly $1,760 among workers who face a deductible for single coverage. That compares with about $1,670 last year.

    Employers, particularly large ones, see a growing need for mental health services, the Kaiser survey found.

    Nearly half of big companies saw an increase in the share of workers using mental health services, and more than a quarter say that more employees are asking for family leave because of mental health issues.

    But many employers don’t feel they have enough providers in their networks to provide timely access to mental health care, Rae said.

    While 82% of firms said they have a sufficient number of primary care providers, only 44% said the same of behavioral health providers.

    Telehealth remains important, with three-quarters of firms saying telemedicine matters “somewhat” or “a great deal” in providing access to mental health services.

    [ad_2]

    Source link

  • Singapore jails man who posed as female gynecologist on Facebook to get intimate photos | CNN

    Singapore jails man who posed as female gynecologist on Facebook to get intimate photos | CNN

    [ad_1]



    CNN
     — 

    A man who fooled dozens of women into sending him photos of their genitalia by posing as a female gynecologist on Facebook has been sentenced to jail in Singapore.

    The state courts on Wednesday found Ooi Chuen Wei, 37, from Malaysia, guilty of “cheating by personation” and sentenced him to three years and four months in prison.

    Ooi used a fake Facebook profile to contact the women, asking them to fill out surveys that included questions about their genitals and sex lives, according to court documents seen by CNN.

    Over a period of four years, he tricked 38 women and received close to 1,000 intimate photos and videos in return.

    The offenses came to light last July when a woman, who had grown suspicious of Ooi and realized there was no such doctor, lodged a police report.

    The police then raided Ooi’s home and seized his devices. During the course of the police investigation, he admitted tricking the women, according to the court documents.

    Deputy public prosecutor R. Arvindren asked for a prison sentence of at least three years and eight months for Ooi, citing the large number of victims and how long Ooi had continued his deception.

    “The accused executed a carefully thought out scheme to satisfy his sexual desires,” Arvindren said.

    “(He) pretended that he was a female doctor and deceived several victims into sending various compromising photographs and videos of themselves. (He) has abused the trust the public has for doctors and he has exploited social media to commit the crimes,” he added.

    [ad_2]

    Source link